Clinical Trial Update: A Safety and Efficacy Study of BCD-080 Compared to Clexan for Deep Vein Thrombosis Prophylaxis at Orthopedic Surgeries [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluated the safety and efficacy of BCD-080 versus Clexan (enoxaparin) for preventing deep vein thrombosis after orthopedic surgery. The stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis

Drugs mentioned

• BCD-080
• Clexan (enoxaparin)

Snippet

Sponsor: Biocad | Conditions: Deep Vein Thrombosis | Phase 3 | Status: COMPLETED | Results posted: 2016-10-24